Key Market Access Trends to Watch in 2024

Pharmaceutical Executive teamed with Archbow Consulting to help market access teams start thinking about how they can tell their story in the year ahead. These five trends detail why evolved preparation, thought, and engagement will be needed to meet transformative changes in 2024. We hope this list gives you the added insight to help you maximize your opportunities over the next year.
How did we do on this list? Is there anything else you would have included? Let us know – we’d love to hear from you.
For additional insights on this topic, you may also enjoy the following related blog posts:
Archbow Consulting helps pharmaceutical and biotech companies in the USA and Europe design, build, and optimize product distribution and patient access strategies. Archbow was founded by industry veterans to meet a need in the marketplace for consulting options that offer diverse real-world experience, are able to leverage deep connections across the industry, and can also provide actionable strategic guidance. We invite you to learn more about our team, services, and clients’ success, and connect with us via email, LinkedIn or subscribing to this blog which you can do below.
Share in
Recent Posts
Mastering 3PL Economics for Manufacturers
Discover how specialized 3PL cost analysis helps manufacturers identify pricing discrepancies and negotiate with confidence.
Preparing for the FDA’s 12-Digit NDC Transition
Manufacturers should begin planning early to assess impacts, align stakeholders, update affected processes, and allow sufficient time for testing and implementation before the March 7, 2033 deadline.
Is Your Specialty Distribution Fee Schedule Keeping Pace?
Specialty distribution fee schedules must evolve with market conditions and service requirements. Archbow provides benchmarking, FMV analysis, and negotiation support to help manufacturers establish informed, defensible agreements.
SUBSCRIBE
Subscribe to receive news and updates from Archbow Consulting
|
|


